Feasibility Trial of the TELL Tool Intervention
Feasibility and Pilot Testing of the TELL Tool Among Gamete and Embryo Donation Recipient Parents
2 other identifiers
interventional
75
1 country
1
Brief Summary
A radical paradigm shift is taking place where technology, notably the explosion in easy accessible direct-to-consumer genetic testing (e.g., 23andMe) and a high consumer interest in genealogy (e.g., Ancestry.com), has hijacked gamete (eggs, sperm) and embryo donation recipient parents' control over whether to inform their children about their donor conception. Historically, the practice of gamete donation has been shrouded in secrecy, however, the skyrocketing use of direct-to-consumer genetic testing means that at any point in an adult life, an uninformed donor-conceived person can learn their DNA does not match their presumed ancestry of their parents and family members, putting into question their genetic relatedness to their parents and launching a spiraling sequence of negative health consequences and trauma. Furthermore, the lack of one's knowledge about actual genetic heritage in the age of precision medicine can be enormously detrimental to health and can result in medical maltreatment, including death. To address this serious problem and in accordance with International Patient Decision Aid Standards, we developed a digital, tailored, multicomponent Tool to Empower ParentaL TeLling and Talking (i.e., TELL Tool). The objective of this R34 study is to examine the feasibility, acceptability, and preliminary effects of the TELL Tool intervention in a pilot randomized-controlled feasibility trial with 60 donor-recipient parents and 10 clinicians to determine intervention viability and inform a larger, efficacy trial. An eBook with content about good parenting principles serves as the attention control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 8, 2021
CompletedFirst Posted
Study publicly available on registry
April 12, 2021
CompletedStudy Start
First participant enrolled
July 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedResults Posted
Study results publicly available
January 11, 2024
CompletedJanuary 11, 2024
January 1, 2024
1.2 years
April 8, 2021
November 21, 2023
January 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Disclosed the Donor Conception to Their Children
Participant's report of current state of disclosure to their child or children. Total score range = 1 (disclosed) 2 (not-disclosed)
Disclosure assessed at 4-week time point. Data for the 12-week time point was missing due to a technology issue.
Secondary Outcomes (3)
Change in Disclosure Intention
Baseline-Change in Disclosure Intention at Immediate posttest-Month 1-Month 3
Change in Disclosure Competence
Baseline-Change in Disclosure Competence at Immediate posttest-Month 1-Month 3
Change in Disclosure Anxiety
Baseline-Change in Disclosure Anxiety at Immediate posttest-Month 1-Month 3
Other Outcomes (3)
Acceptability of the TELL Tool and eBook
Immediate posttest
Acceptability of the TELL Tool, eBook and Study Protocol
Month 15
Pretesting of the Measures
Before baseline
Study Arms (2)
TELL Tool Group
EXPERIMENTALParents in the TELL Tool group will complete a decision support aid that has four interactive, multimedia and multicomponent modules that will be administered digitally. It will take parents about 60 minutes to complete the TELL Tool.
eBook Attention-Control
ACTIVE COMPARATORParents in the eBook attention-control group will complete one interactive, multimedia and multicomponent program that contains information about good parenting principles and is administered digitally. It will take parents about 60 minutes to complete the eBook attention control.
Interventions
A 60-minute session with decision support information delivered digitally to parents at their homes or other private, quiet location.
A 60-minute session with good parenting principles delivered digitally to parents at their homes or other private, quiet location.
Eligibility Criteria
You may qualify if:
- Reside in the United States or one of its recognized territories
- Conceived 1 or more children via gamete (egg/sperm) or embryo donation who are currently between the ages of 1 - 16 years of age
- Have not informed their child(ren) about their donor conception origins
- Are 21 years-of-age or older
- English speaking
- Active practice as a healthcare professional (e.g., nurse, physician, psychologist, social worker)
- Provide education and/or counseling to gamete (eggs, sperm) and/or embryo donation recipient parents about disclosure to their children in the United States or one of its recognized territories
- Able to provide feedback and insight about new tools to assist gamete (eggs, sperm) and/or embryo donation recipient parents with disclosure to their donor-conceived children
- Are 21 years-of-age or older
- English speaking
You may not qualify if:
- Have already disclosed the donor conception to their donor-conceived child or children
- Reside outside of the United States or one of its recognized territories
- Not directly involved in providing education and/or counseling to gamete (eggs, sperm) and/or embryo donation recipient parents about disclosure to their children
- Are a member of the research team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago
Chicago, Illinois, 60605, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Patricia Hershberger
- Organization
- University of Illinois Chicago
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia Hershberger, PhD
University of Illinois Chicago
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Parents will be randomized into two groups (either the TELL Tool group or the attention control eBook group) using a permuted block approach that is stratified by the age categories of the parent's children and using an online (REDCap) randomization module.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 8, 2021
First Posted
April 12, 2021
Study Start
July 26, 2021
Primary Completion
September 30, 2022
Study Completion
July 31, 2023
Last Updated
January 11, 2024
Results First Posted
January 11, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
When we publish our results, electronic copies of publications will be deposited in PubMed Central within four weeks of acceptance by a journal. We will also submit our results to ClinicalTrials.gov Protocol Registration and Results System as required.